# Roberto Della Marina

> Roberto Della Marina is a Series A investor at Venture Factory backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Venture Factory](https://shizune.co/investors/profile/venture-factory-5ed0)
- Location: Milano, Italy
- Total investments: 2
- Last investment: Oct 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/robertodellamarina/
- Website: https://www.venturefactory.tech

Roberto Della Marina is a Series A investor at Venture Factory in Milano focused on Medical and Health Care. Roberto Della Marina - Managing Partner @ Venture Factory

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Machine Learning | 1 | 50% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aindo | At Aindo, our mission is to enable Artificial Intelligence (AI) to add value to society while respecting people's rights and freedoms. We achieve this mission through the Aindo Synthetic Data Platform.Synthetic data form a revolutionary new paradigm in privacy protection and fairness. They are hyper-realistic, yet artificial and devoid ofsensitive information. They replace personal data or rebalance biased datasets for safe and fair analysis. Synthetic data allows us to responsibly seize the wealth of opportunities AI presents. This is invaluable in sectors such as healthcare, finance, infrastructure, and policymaking.Aindo is one of the first teams dedicated to synthetic data. We actively further the state-of-the-art. Our platform’s best-in-class performance and advanced capabilities reflect this. We offer an effortless user-experience. This allows both experts and non-experts to integrate synthetic data directly in their data projects, even when their data assets are siloed; unstructured; unlabeled; and contain advanced data types and formats. | $6.3M | Series A | Oct 18, 2023 |  |
| Sibylla Biotech | Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas. | $23M | Series A | Oct 04, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund, 1 deal together
- [Claris Ventures](https://shizune.co/investors/profile/claris-ventures) — VC Fund, 1 deal together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 1 deal together
- [Indaco Venture Partners](https://shizune.co/investors/profile/indaco-venture-partners) — VC Fund, 1 deal together
- [Seroba Life Sciences](https://shizune.co/investors/profile/seroba-life-sciences) — VC Fund, 1 deal together
- [United Ventures](https://shizune.co/investors/profile/united-ventures) — VC Fund, 1 deal together

## About Venture Factory

VC Fund



2 contacts available at Venture Factory.

| Name | Title | Profile |
| --- | --- | --- |
| Roberto Della Marina | Managing Partner | https://shizune.co/investors/profile/roberto-marina |
| Nicola Redi | Managing Partner | https://shizune.co/investors/profile/nicola-redi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Roberto Della Marina invest in?

Roberto Della Marina invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Roberto Della Marina last invest?

The most recent investment recorded for Roberto Della Marina closed in Oct 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co